<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Imipramine for neuropathic pain in adults - Hearn, L - 2014 | Cochrane Library</title> <meta content="Imipramine for neuropathic pain in adults - Hearn, L - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010769.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Imipramine for neuropathic pain in adults - Hearn, L - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010769.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010769.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Imipramine for neuropathic pain in adults" name="citation_title"/> <meta content="Leslie Hearn" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="Sheena Derry" name="citation_author"/> <meta content="sheena.derry@retired.ox.ac.uk" name="citation_author_email"/> <meta content="Tudor Phillips" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="R Andrew Moore" name="citation_author"/> <meta content="Philip J Wiffen" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD010769.pub2" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/05/19" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010769.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010769.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010769.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Analgesics [*therapeutic use]; Antidepressive Agents, Tricyclic [*therapeutic use]; Diabetic Neuropathies [*drug therapy]; Imipramine [*therapeutic use]; Neuralgia [*drug therapy]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010769.pub2&amp;doi=10.1002/14651858.CD010769.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010769.pub2&amp;doi=10.1002/14651858.CD010769.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010769.pub2&amp;doi=10.1002/14651858.CD010769.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010769.pub2&amp;doi=10.1002/14651858.CD010769.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010769.pub2&amp;doi=10.1002/14651858.CD010769.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010769.pub2&amp;doi=10.1002/14651858.CD010769.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010769.pub2&amp;doi=10.1002/14651858.CD010769.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010769.pub2&amp;doi=10.1002/14651858.CD010769.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010769.pub2&amp;doi=10.1002/14651858.CD010769.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010769.pub2&amp;doi=10.1002/14651858.CD010769.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010769.pub2&amp;doi=10.1002/14651858.CD010769.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010769.pub2&amp;doi=10.1002/14651858.CD010769.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010769.pub2&amp;doi=10.1002/14651858.CD010769.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010769.pub2&amp;doi=10.1002/14651858.CD010769.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010769.pub2&amp;doi=10.1002/14651858.CD010769.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010769.pub2&amp;doi=10.1002/14651858.CD010769.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010769.pub2&amp;doi=10.1002/14651858.CD010769.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010769.pub2&amp;doi=10.1002/14651858.CD010769.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010769.pub2&amp;doi=10.1002/14651858.CD010769.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010769.pub2&amp;doi=10.1002/14651858.CD010769.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010769.pub2&amp;doi=10.1002/14651858.CD010769.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010769.pub2&amp;doi=10.1002/14651858.CD010769.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010769.pub2&amp;doi=10.1002/14651858.CD010769.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="loVWuZlx";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010769\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010769\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010769\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010769\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","hr","fr","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010769.pub2",title:"Imipramine for neuropathic pain in adults",firstPublishedDate:"May 19, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pain, Palliative and Supportive Care Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=loVWuZlx&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010769.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010769.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010769.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010769.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010769.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010769.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010769.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010769.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010769.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010769.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010769.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010769.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010769.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010769.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3936 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010769.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010769.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010769.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010769.pub2/full#CD010769-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010769.pub2/full#CD010769-sec-0085"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010769.pub2/full#CD010769-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010769.pub2/full#CD010769-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010769.pub2/full#CD010769-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010769.pub2/full#CD010769-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010769.pub2/full#CD010769-sec-0059"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010769.pub2/full#CD010769-sec-0079"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010769.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010769.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010769.pub2/appendices#CD010769-sec-0089"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010769.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010769.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010769.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010769.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010769.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010769.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010769.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010769.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Imipramine for neuropathic pain in adults</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010769.pub2/information#CD010769-cr-0002">Leslie Hearn</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010769.pub2/information#CD010769-cr-0003"><i class="icon corresponding-author fa fa-envelope"></i>Sheena Derry</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010769.pub2/information#CD010769-cr-0004">Tudor Phillips</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010769.pub2/information#CD010769-cr-0005">R Andrew Moore</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010769.pub2/information#CD010769-cr-0006">Philip J Wiffen</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010769.pub2/information/en#CD010769-sec-0099">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 19 May 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010769.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010769.pub2">https://doi.org/10.1002/14651858.CD010769.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010769-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010769-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010769-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010769-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010769-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010769-abs-0010">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010769-abs-0001" lang="en"> <section id="CD010769-sec-0001"> <h3 class="title" id="CD010769-sec-0001">Background</h3> <p>Antidepressants are widely used to treat chronic neuropathic pain (pain due to nerve damage), usually in doses below those at which they exert antidepressant effects. An earlier review that included all antidepressants for neuropathic pain is being replaced by new reviews of individual drugs examining individual neuropathic pain conditions. </p> <p>Imipramine is a tricyclic antidepressant that is occasionally used to treat neuropathic pain. </p> </section> <section id="CD010769-sec-0002"> <h3 class="title" id="CD010769-sec-0002">Objectives</h3> <p>To assess the analgesic efficacy of imipramine for chronic neuropathic pain in adults, and to assess the associated adverse events. </p> </section> <section id="CD010769-sec-0003"> <h3 class="title" id="CD010769-sec-0003">Search methods</h3> <p>We searched CENTRAL, MEDLINE, and EMBASE on 18 November 2013, as well as the reference lists of retrieved papers and other reviews. We also used our own handsearched database for older studies, and two clinical trials databases. </p> </section> <section id="CD010769-sec-0004"> <h3 class="title" id="CD010769-sec-0004">Selection criteria</h3> <p>We included randomised, double‐blind studies of at least two weeks' duration comparing imipramine with placebo or another active treatment in chronic neuropathic pain. Participants were adults aged 18 and over. We included only articles with full journal publication and extended trial abstracts and summaries. </p> </section> <section id="CD010769-sec-0005"> <h3 class="title" id="CD010769-sec-0005">Data collection and analysis</h3> <p>Two review authors independently extracted efficacy and adverse event data, and examined issues of study quality. We performed analysis using three tiers of evidence. First tier evidence was derived from data meeting current best standards and subject to minimal risk of bias (outcome equivalent to substantial pain intensity reduction, intention‐to‐treat analysis without imputation for dropouts; at least 200 participants in the comparison, 8 to 12 weeks duration, parallel design); second tier from data that failed to meet one or more of these criteria and were considered at some risk of bias but with adequate numbers in the comparison; and third tier from data involving small numbers of participants which was considered very likely to be biased or used outcomes of limited clinical utility, or both. </p> </section> <section id="CD010769-sec-0006"> <h3 class="title" id="CD010769-sec-0006">Main results</h3> <p>Five studies treated 168 participants with painful diabetic neuropathy or polyneuropathy. The mean age in individual studies was between 47 and 56 years. Four studies used a cross‐over, and one a parallel group design; 126 participants were randomised to receive imipramine 25 mg to 350 mg daily (most took 100 mg to 150 mg daily). Comparators were placebo (an active placebo in one study), paroxetine, mianserin, venlafaxine, and amitriptyline, and treatment was given for 2 to 12 weeks. All studies had one or more sources of potential major bias. </p> <p>No study provided first or second tier evidence for any outcome. No data were available on the proportion of people with at least 50% or 30% reduction in pain or equivalent, and data were available from only one study for our other primary outcome of Patient Global Impression of Change, reported as patient evaluation of pain relief of complete or good. No pooling of data was possible, but third tier evidence in individual studies indicated some improvement in pain relief with imipramine compared with placebo, although this is was very low quality evidence, derived mainly from group mean data and completer analyses, in small, short duration studies where major bias is possible. </p> <p>Four studies reported some information about adverse events, but reporting was inconsistent and fragmented, and the quality of evidence was very low. Participants taking imipramine generally experienced more adverse events, notably dry mouth, and a higher rate of withdrawal due to adverse events, than did participants taking placebo. </p> </section> <section id="CD010769-sec-0007"> <h3 class="title" id="CD010769-sec-0007">Authors' conclusions</h3> <p>This review found little evidence to support the use of imipramine to treat neuropathic pain. There was very low quality evidence of benefit but this came from studies that were methodologically flawed and potentially subject to major bias. Effective medicines with much greater supportive evidence are available. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010769-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010769-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010769-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010769-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010769-abs-0007">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD010769-abs-0004">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010769-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010769-abs-0003" lang="en"> <h3>Imipramine for neuropathic pain in adults</h3> <p>Neuropathic pain is pain coming from damaged nerves. It is different from pain messages carried along healthy nerves from damaged tissue (as in a fall, a cut, or an arthritic knee). Neuropathic pain is treated with different medicines than pain from damaged tissue. Medicines like paracetamol or ibuprofen are usually not effective in neuropathic pain, while medicines that are sometimes used to treat depression or epilepsy can be very effective in some people with neuropathic pain. </p> <p>Imipramine is from the same class of medicines as amitriptyline, which is widely recommended for treating neuropathic pain; imipramine may also be useful in these painful conditions. In 2013 we performed searches to look for clinical trials in which imipramine was used to treat neuropathic pain. </p> <p>We found five studies involving 168 participants with painful diabetic neuropathy or polyneuropathy. Studies were randomised and double‐blind, but all had one or more sources of potential major bias that could lead to overestimation of efficacy. It was not possible to combine information from the different studies, but individually they indicated some benefit from imipramine (usually at a dose between 100 mg and 150 mg daily) compared with placebo, at the expense of increased adverse events. </p> <p>There was too little information, which was of inadequate quality, to be sure that imipramine works as a pain medicine in neuropathic pain due to diabetes or due to damage to multiple nerves. There was no information about other types of neuropathic pain. Other medicines have been shown to be effective. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010769-sec-0085" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010769-sec-0085"></div> <h3 class="title" id="CD010769-sec-0086">Implications for practice</h3> <section id="CD010769-sec-0086"> <p>This review found little evidence to support the use of imipramine to treat neuropathic pain. There was very low quality evidence of some benefit in the proportion of people with Patient Global Impression of Change much or very much improved and with at least 50% or at least 30% reductions in neuropathy symptom scores, but this came from studies that were methodologically flawed and potentially subject to major bias. There may be a role in patients who have not obtained pain relief from other treatments. </p> </section> <h3 class="title" id="CD010769-sec-0087">Implications for research</h3> <section id="CD010769-sec-0087"> <p>There are reasonable levels of evidence for the benefit of other anti‐epileptic and antidepressant drugs in the treatment of chronic neuropathic pain. </p> <p>Larger, better‐designed studies would provide more definitive conclusions on the efficacy of imipramine, but it is unlikely that these will be carried out, given the age of the drug and the alternatives available, or that they could be justified on the basis of the available evidence. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010769-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010769-sec-0029"></div> <div class="table" id="CD010769-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Imipramine compared with placebo for painful diabetic neuropathy and polyneuropathy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population: neuropathic pain (5 studies in painful diabetic neuropathy and polyneuropathy)</b> </p> <p><b>Settings: community</b> </p> <p><b>Intervention: imipramine 25 to 350 mg daily</b> </p> <p><b>Comparison: placebo</b> </p> </td> </tr> <tr class="table-header separated"> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Probable outcome with comparator (placebo)</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Probable outcome with intervention</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>RR (95% CI)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>At least 50% reduction in pain or equivalent</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"Moderate" benefit</p> <p>At least 30% reduction in pain</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion below 30/100 mm on VAS</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Patient Global Impression of Change much or very much improved</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>2/40</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>9/40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not calculated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40 participants</p> <p>1 study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Small numbers of participants in 1 study, cross‐over design</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse event withdrawals</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>3/109</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>3 during dose‐finding open label treatment (denominator unknown)</p> <p>4/109 during double blind treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not calculated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>109 participants</p> <p>4 studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Small numbers of studies and participants</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>1 "unrelated" hospitalisation for a "pronounced" urinary tract infection. Treatment group not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not calculated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>168 participants</p> <p>5 studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Small numbers of studies and participants</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Death</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>None reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>168 participants</p> <p>5 studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Small numbers of studies and participants</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>CI: confidence interval; RR: risk ratio.</p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010769-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010769-sec-0030"></div> <p>Imipramine is a tricyclic antidepressant that is sometimes used to treat chronic neuropathic pain (pain due to nerve damage or changes in the central nervous system (CNS)). Its use is not specifically recommended, but it is listed alongside other tricyclic antidepressants in some treatment guidelines, although this is an unlicensed indication (<a href="./references#CD010769-bbs2-0012" title="AttalN , CruccuG , BaronR , HaanpääM , HanssonP , JensenTS , et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. European Journal of Neurology2010;17(9):1113‐e88. [DOI: 10.1111/j.1468‐1331.2010.02999.x] ">Attal 2010</a>; <a href="./references#CD010769-bbs2-0021" title="FinnerupNB , SindrupSH , JensenTS . The evidence for pharmacological treatment of neuropathic pain. Pain2010;150(3):573‐81. [DOI: 10.1016/j.pain.2010.06.019] ">Finnerup 2010</a>; <a href="./references#CD010769-bbs2-0054" title="MoulinDE , ClarkAJ , GilronI , WareMA , WatsonCP , SessleBJ , et al. Pharmacological management of chronic neuropathic pain ‐ consensus statement and guidelines from the Canadian Pain Society. Pain Research and Management2007;12(1):13‐21. ">Moulin 2007</a>). </p> <section id="CD010769-sec-0031"> <h3 class="title" id="CD010769-sec-0031">Description of the condition</h3> <p>The 2011 International Association for the Study of Pain (IASP) definition of neuropathic pain is "pain caused by a lesion or disease of the somatosensory system" (<a href="./references#CD010769-bbs2-0026" title="JensenTS , BaronR , HaanpääM , KalsoE , LoeserJD , RiceAS , et al. A new definition of neuropathic pain. Pain2011; Vol. 152, issue 10:2204‐5. [DOI: 10.1016/j.pain.2011.06.017] ">Jensen 2011</a>) based on an earlier consensus meeting (<a href="./references#CD010769-bbs2-0067" title="TreedeRD , JensenTS , CampbellJN , CruccuG , DostrovskyJO , GriffinJW , et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology2008;70(18):1630‐5. [DOI: 10.1212/01.wnl.0000282763.29778.59] ">Treede 2008</a>). Neuropathic pain may be caused by nerve damage, but is often followed by changes in the CNS (<a href="./references#CD010769-bbs2-0035" title="MoissetX , BouhassiraD . Brain imaging of neuropathic pain. Neuroimaging2007;37(Suppl 1):S80‐8. [DOI: 10.1016/j.neuroimage.2007.03.054] ">Moisset 2007</a>). It is complex (<a href="./references#CD010769-bbs2-0011" title="ApkarianAV , HashmiJA , BalikiMN . Pain and the brain: specificity and plasticity of the brain in clinical chronic pain. Pain2011;152(3 Suppl):S49‐64. [DOI: 10.1016/j.pain.2010.11.010] ">Apkarian 2011</a>; <a href="./references#CD010769-bbs2-0066" title="TraceyI . Can neuroimaging studies identify pain endophenotypes in humans?. Nature Reviews Neurology2011;7(3):173‐81. [doi: 10.1038/nrneurol.2011.4] ">Tracey 2011</a>), and neuropathic pain features can be found in patients with joint pain (<a href="./references#CD010769-bbs2-0061" title="SoniA , BatraR , GwilymS , SpectorT , HartD , ArdenN , et al. Neuropathic features of joint pain: A community‐based study. Arthritis &amp; Rheumatism2013;April 1:Epub ahead of print. [DOI: 10.1002/art.37962] ">Soni 2013</a>). Many people with neuropathic pain conditions are significantly disabled by moderate or severe pain for many years. </p> <p>Chronic painful conditions comprise five of the 11 top‐ranking conditions for years lived with disability in 2010 (<a href="./references#CD010769-bbs2-0068" title="VosT , FlaxmanAD , NaghaviM , LozanoR , MichaudC , EzzatiM , et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet2012;380(9859):2163‐96. [DOI: 10.1016/S0140‐6736(12)61729‐2] ">Vos 2012</a>), and are responsible for considerable loss of quality of life, employment, and increased health costs (<a href="./references#CD010769-bbs2-0050" title="MooreRA , DerryS , TaylorRS , StraubeS , PhillipsCJ . The costs and consequences of adequately managed chronic non‐cancer pain and chronic neuropathic pain. Pain Practice2013;March 6:Epub ahead of print. [DOI: 10.1111/papr.12050] ">Moore 2013a</a>). </p> <p>In primary care in the UK the incidences, per 100,000 person years observation, have been reported as 28 (95% confidence interval (CI) 27 to 30) for postherpetic neuralgia, 27 (95% CI 26 to 29) for trigeminal neuralgia, 0.8 (95% CI 0.6 to 1.1) for phantom limb pain, and 21 (95% CI 20 to 22) for painful diabetic neuropathy (<a href="./references#CD010769-bbs2-0023" title="HallGC , CarrollD , McQuayHJ . Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002‐2005. BMC Family Practice2008;9:26. [DOI: 10.1186/1471‐2296‐9‐26] ">Hall 2008</a>). Estimates vary between studies, often because of small numbers of cases. The incidence of trigeminal neuralgia has been estimated at 4 in 100,000 per year (<a href="./references#CD010769-bbs2-0027" title="KatusicS , WilliamsDB , BeardCM , BergstralhEJ , KurlandLT . Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota,1945‐1984. Neuroepidemiology1991;10:276‐81. ">Katusic 1991</a>; <a href="./references#CD010769-bbs2-0059" title="RappaportZH , DevorM . Trigeminal neuralgia: the role of self‐sustaining discharge in the trigeminal ganglion. Pain1994;56:127‐38. [DOI: 10.1016/0304‐3959(94)90086‐8] ">Rappaport 1994</a>), while more recently, a study of facial pain in The Netherlands found incidences per 100,000 person years of 12.6 for trigeminal neuralgia and 3.9 for postherpetic neuralgia (<a href="./references#CD010769-bbs2-0030" title="KoopmanJS , DielemanJP , HuygenFJ , deMosM , MartinCG , SturkenboomMC . Incidence of facial pain in the general population. Pain2009;147(1‐3):122‐7. [DOI: 10.1016/j.pain.2009.08.023] ">Koopman 2009</a>). A systematic review of chronic pain demonstrated that some neuropathic pain conditions, such as painful diabetic neuropathy, can be more common, with <i>prevalence</i> rates up to 400 per 100,000 person years (<a href="./references#CD010769-bbs2-0034" title="McQuayHJ , SmithLA , MooreRA . Chronic Pain. In: StevensA , RafteryJ , MantJ , SimpsonS editor(s). Health Care Needs Assessment. 3rd Edition. Oxford: Radcliffe Publishing, 2007. [ISBN: 978‐1‐84619‐063‐6] ">McQuay 2007</a>) illustrating how common the condition was as well as its chronicity. The prevalence of neuropathic pain was reported as being 3.3% in Austria (<a href="./references#CD010769-bbs2-0022" title="GustorffB , DornerT , LikarR , GrisoldW , LawrenceK , SchwarzF , et al. Prevalence of self‐reported neuropathic pain and impact on quality of life: a prospective representative survey. Acta Anaesthesiologica Scandinavica2008;52(1):132‐6. [DOI: 10.1111/j.1399‐6576.2007.01486.x] ">Gustorff 2008</a>), 6.9% in France (<a href="./references#CD010769-bbs2-0014" title="BouhassiraD , Lantéri‐MinetM , AttalN , LaurentB , TouboulC . Prevalence of chronic pain with neuropathic characteristics in the general population. Pain2008;136(3):380‐7. [DOI: 10.1016/j.pain.2007.08.013] ">Bouhassira 2008</a>), as high as 8% in the UK (<a href="./references#CD010769-bbs2-0065" title="TorranceN , SmithBH , BennettMI , LeeAJ . The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. Journal of Pain2006;7(4):281‐9. [DOI: 10.1016/j.jpain.2005.11.008] ">Torrance 2006</a>), and about 7% in a systematic review of studies published since 2000 (<a href="./references#CD010769-bbs2-0050" title="MooreRA , DerryS , TaylorRS , StraubeS , PhillipsCJ . The costs and consequences of adequately managed chronic non‐cancer pain and chronic neuropathic pain. Pain Practice2013;March 6:Epub ahead of print. [DOI: 10.1111/papr.12050] ">Moore 2013a</a>). Some forms of neuropathic pain, such as diabetic neuropathy and post surgical chronic pain (which is often neuropathic in origin), are increasing (<a href="./references#CD010769-bbs2-0023" title="HallGC , CarrollD , McQuayHJ . Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002‐2005. BMC Family Practice2008;9:26. [DOI: 10.1186/1471‐2296‐9‐26] ">Hall 2008</a>). </p> <p>Neuropathic pain is known to be difficult to treat effectively, with only a minority of individuals experiencing a clinically relevant benefit from any one intervention. A multidisciplinary approach is now advocated, with pharmacological interventions being combined with physical and/or cognitive interventions. Conventional analgesics are usually not effective. Some patients may derive some benefit from a topical lidocaine patch or low concentration topical capsaicin, although evidence about benefits is uncertain (<a href="./references#CD010769-bbs2-0016" title="DerryS , MooreRA . Topical capsaicin (low concentration) for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews2012, Issue 9. [DOI: 10.1002/14651858.CD010111] ">Derry 2012</a>; <a href="./references#CD010769-bbs2-0028" title="KhaliqW , AlamS , PuriN . Topical lidocaine for the treatment of postherpetic neuralgia. Cochrane Database of Systematic Reviews2007, Issue 2. [DOI: 10.1002/14651858.CD004846.pub2] ">Khaliq 2007</a>). High concentration topical capsaicin may benefit some patients with postherpetic neuralgia (<a href="./references#CD010769-bbs2-0017" title="DerryS , Sven‐RiceA , ColeP , TanT , MooreRA . Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD007393.pub3] ">Derry 2013</a>). Treatment is more usually by so‐called unconventional analgesics such as antidepressants like duloxetine and amitriptyline (<a href="./references#CD010769-bbs2-0032" title="LunnMP , HughesRA , WiffenPJ . Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database of Systematic Reviews2014, Issue 1. [DOI: 10.1002/14651858.CD007115.pub3] ">Lunn 2014</a>; <a href="./references#CD010769-bbs2-0048" title="MooreRA , DerryS , AldingtonD , ColeP , WiffenPJ . Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.CD008242.pub2] ">Moore 2012a</a>; <a href="./references#CD010769-bbs2-0064" title="SultanA , GaskellH , DerryS , MooreRA . Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials. BMC Neurology2008;8:29. [DOI: 10.1186/1471‐2377‐8‐29] ">Sultan 2008</a>) or antiepileptics like gabapentin or pregabalin (<a href="./references#CD010769-bbs2-0038" title="MooreRA , StraubeS , WiffenPJ , DerryS , McQuayHJ . Pregabalin for acute and chronic pain in adults. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD007076.pub2] ">Moore 2009a</a>; <a href="./references#CD010769-bbs2-0045" title="MooreRA , WiffenPJ , DerryS , McQuayHJ . Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews2011, Issue 3. [DOI: 10.1002/14651858.CD007938.pub2] ">Moore 2011a</a>). An overview of treatment guidelines identified general similarities based on the evidence available, but guidelines are not always consistent with one another (<a href="./references#CD010769-bbs2-0058" title="O'Connor , AB , DworkinRH . Treatment of neuropathic pain: an overview of recent guidelines. American Journal of Medicine2009;122(10 Suppl):S22‐32. [DOI: 10.1016/j.amjmed.2009.04.007] ">O'Connor 2009</a>). The proportion of patients who achieve worthwhile pain relief (typically at least 50% pain intensity reduction (<a href="./references#CD010769-bbs2-0051" title="MooreRA , StraubeS , AldingtonD . Pain measures and cut‐offs ‐ 'no worse than mild pain' as a simple, universal outcome. Anaesthesia2013;68(4):400‐12. [DOI: 10.1111/anae.12148] ">Moore 2013b</a>)) is small, generally 10% to 25% more than with placebo, with numbers needed to treat to benefit (NNTs) usually between 4 and 10 (<a href="./references#CD010769-bbs2-0052" title="MooreA , DerryS , EcclestonC , KalsoE . Expect analgesic failure; pursue analgesic success. BMJ2013;346:f2690. [DOI: 10.1136/bmj.f2690] ">Moore 2013c</a>). </p> </section> <section id="CD010769-sec-0032"> <h3 class="title" id="CD010769-sec-0032">Description of the intervention</h3> <p>Imipramine is a tricyclic antidepressant (TCA) that is most commonly used to treat depressive illness in adults and nocturnal enuresis in children. It is partially converted in the body to an active metabolite, desipramine, another TCA. Imipramine is not licensed in the UK for treating neuropathic pain but is used for this condition. It is also used around the world for neuropathic pain, irrespective of licensing. </p> <p>Imipramine is available as tablets (10 mg and 25 mg) and as an oral liquid. For treating neuropathic pain, typical starting dosages are between 10 mg and 25 mg daily, usually taken at night, increasing to 75 mg daily if necessary. The main adverse effects are due to its anticholinergic activity and include dry mouth, weight gain, and drowsiness (although it is less sedating than amitriptyline). </p> </section> <section id="CD010769-sec-0033"> <h3 class="title" id="CD010769-sec-0033">How the intervention might work</h3> <p>The mechanism of action of imipramine in the treatment of neuropathic pain remains uncertain, although it is known to be a strong reuptake inhibitor of serotonin and, to a lesser extent, norepinephrine (<a href="./references#CD010769-bbs2-0069" title="WatsonCPN , GilronI , PollockBG , Lipman , AG , SmithMT . Antidepressant analgesics. In: McMahonSB , KoltzenburgM , TraceyI , TurkDC editor(s). Wall and Melzack's Textbook of Pain. 6th Edition. Philadelphia: Elsevier Saunders, 2013:465‐90. [ISBN: 978‐0‐7020‐4059‐7] ">Watson 2013</a>). Its active metabolite, desipramine, is conversely a very strong reuptake inhibitor of norepinephrine and, to a lesser extent, serotonin. The mechanism is likely to differ from that in depression since analgesia with TCAs is often achieved at lower doses than are needed for antidepressant effects. An alternative mechanism is likely to involve its action, and that of desipramine (as with many other analgesics) in blocking sodium channels in nerve membranes. TCAs are known to block sodium channels, binding at the local anaesthetic site at blood levels found at therapeutically relevant doses. </p> </section> <section id="CD010769-sec-0034"> <h3 class="title" id="CD010769-sec-0034">Why it is important to do this review</h3> <p>The earlier review of antidepressants for neuropathic pain (<a href="./references#CD010769-bbs2-0070" title="SaartoT , WiffenPJ . Antidepressants for neuropathic pain. Cochrane Database of Systematic Reviews2007, Issue 4. [DOI: 10.1002/14651858.CD005454.pub2] ">Saarto 2007</a>) is being replaced by separate reviews for individual drugs due to the large amount of data now available for some of them. These separate reviews will use more stringent criteria of validity, which include the level of response obtained, duration of the study, and method of imputation of missing data (<a href="./references#CD010769-bbs2-0049" title="MooreRA , StraubeS , EcclestonC , DerryS , AldingtonD , WiffenP , et al. Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses. Pain2012;153(2):265‐8. [DOI: 10.1016/j.pain.2011.10.004] ">Moore 2012b</a>). The individual reviews will be included in an overview of antidepressant drugs for neuropathic pain. <a href="./appendices#CD010769-sec-0090">Appendix 1</a> gives details of recent changes to the thinking about chronic pain and evidence. </p> <p>This Cochrane review assesses evidence in ways that make both statistical and clinical sense, and uses developing criteria for what constitutes reliable evidence in chronic pain (<a href="./references#CD010769-bbs2-0040" title='MooreRA , EcclestonC , DerryS , WiffenP , BellRF , StraubeS , et al. "Evidence" in chronic pain ‐ establishing best practice in the reporting of systematic reviews. Pain2010;150(3):386‐9. [DOI: doi:10.1016/j.pain.2010.05.011] '>Moore 2010a</a>). Trials included and analysed meet a minimum of reporting quality (blinding, randomisation), validity (duration, dose and timing, diagnosis, outcomes, etc) and size (ideally at least 500 participants in a comparison in which the NNT is four or above (<a href="./references#CD010769-bbs2-0036" title="MooreRA , GavaghanD , TramèrMR , CollinsSL , McQuayHJ . Size is everything ‐ large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain1998;78(3):209‐16. [DOI: 10.1016/S0304‐3959(98)00140‐7] ">Moore 1998</a>)). This sets high standards and marks a departure from how reviews have been done previously. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010769-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010769-sec-0035"></div> <p>To assess the analgesic efficacy of imipramine for chronic neuropathic pain in adults and to assess the associated adverse events. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010769-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010769-sec-0036"></div> <section id="CD010769-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010769-sec-0038"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials (RCTs) with at least 10 participants per treatment group and double‐blind assessment of participant outcomes following two weeks of treatment or longer, although the emphasis of the review was on studies of eight weeks or longer. We required full journal publication, with the exception of online clinical trial results summaries of otherwise unpublished clinical trials and abstracts with sufficient data for analysis. We did not include short abstracts (usually meeting reports). We excluded studies that were non‐randomised, studies of experimental pain, case reports and clinical observations. </p> </section> <section id="CD010769-sec-0039"> <h4 class="title">Types of participants</h4> <p>Studies included adult participants aged 18 years and over. Participants could have one or more of a wide range of chronic neuropathic pain conditions including (but not limited to): </p> <p> <ul id="CD010769-list-0001"> <li> <p>cancer‐related neuropathy;</p> </li> <li> <p>central neuropathic pain;</p> </li> <li> <p>complex regional pain syndrome (CRPS) Type II;</p> </li> <li> <p>human immunodeficiency virus (HIV) neuropathy;</p> </li> <li> <p>painful diabetic neuropathy;</p> </li> <li> <p>phantom limb pain;</p> </li> <li> <p>postherpetic neuralgia;</p> </li> <li> <p>postoperative or traumatic neuropathic pain;</p> </li> <li> <p>spinal cord injury;</p> </li> <li> <p>trigeminal neuralgia;</p> </li> </ul> </p> <p>and</p> <p> <ul id="CD010769-list-0002"> <li> <p>CRPS Type I.</p> </li> </ul> </p> <p>If studies included participants with more than one type of neuropathic pain we planned to analyse results according to the primary condition. Migraine and headache studies were excluded as they are the subject of another Cochrane review (<a href="./references#CD010769-bbs2-0015" title="ChronicleEP , MullenersWM . Anticonvulsant drugs for migraine prophylaxis. Cochrane Database of Systematic Reviews2004, Issue 3. [DOI: 10.1002/14651858.CD003226.pub2] ">Chronicle 2004</a>). </p> </section> <section id="CD010769-sec-0040"> <h4 class="title">Types of interventions</h4> <p>Oral imipramine, at any dose, administered for the relief of neuropathic pain and compared to placebo or any active comparator. </p> </section> <section id="CD010769-sec-0041"> <h4 class="title">Types of outcome measures</h4> <p>Studies used a variety of outcome measures, with the majority using subjective scales (categorical scale, numerical rating scale (NRS) or visual analogue scale (VAS)) for pain intensity or pain relief, or both. We were particularly interested in Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) definitions for moderate and substantial benefit in chronic pain studies (<a href="./references#CD010769-bbs2-0018" title="DworkinRH , TurkDC , WyrwichKW , BeatonD , CleelandCS , FarrarJT , et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. Journal of Pain2008;9(2):105‐21. [DOI: 10.1016/j.jpain.2007.09.005] ">Dworkin 2008</a>). These are defined as at least 30% pain relief over baseline (moderate), at least 50% pain relief over baseline (substantial), much or very much improved on Patient Global Impression of Change (PGIC) (moderate), and very much improved on PGIC (substantial). These outcomes concentrate on dichotomous outcomes where pain responses do not follow a normal (Gaussian) distribution. People with chronic pain desire high levels of pain relief, ideally more than 50%, and with pain not worse than mild (<a href="./references#CD010769-bbs2-0057" title="O'BrienEM , StaudRM , HassingerAD , McCullochRC , CraggsJG , AtchisonJW , et al. Patient‐centered perspective on treatment outcomes in chronic pain. Pain Medicine2010;11(1):6‐15. [DOI: 10.1111/j.1526‐4637.2009.00685.x] ">O'Brien 2010</a>). </p> <p>We have included a 'Summary of findings' table as set out in the author guide (<a href="./references#CD010769-bbs2-0013" title="PaPaS author and referee guidance. http://papas.cochrane.org/papas‐documents (accessed 22 January 2013). ">AUREF 2012</a>), which includes outcomes of at least 50% and at least 30% pain intensity reduction, PGIC, adverse event withdrawals, serious adverse events and death. </p> <section id="CD010769-sec-0042"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD010769-list-0003"> <li> <p>Patient‐reported pain relief of 30% or greater.</p> </li> <li> <p>Patient‐reported pain relief of 50% or greater.</p> </li> <li> <p>PGIC much or very much improved.</p> </li> <li> <p>PGIC very much improved.</p> </li> </ol> </p> </section> <section id="CD010769-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD010769-list-0004"> <li> <p>Any pain‐related outcome indicating some improvement.</p> </li> <li> <p>Withdrawals due to lack of efficacy.</p> </li> <li> <p>Participants experiencing any adverse event.</p> </li> <li> <p>Participants experiencing any serious adverse event. Serious adverse events typically include any untoward medical occurrence or effect that at any dose results in death, is life‐threatening, requires hospitalisation or prolongation of existing hospitalisation, results in persistent or significant disability or incapacity, is a congenital anomaly or birth defect, is an ‘important medical event’ that may jeopardise the patient, or may require an intervention to prevent one of the above characteristics/consequences. </p> </li> <li> <p>Withdrawals due to adverse events.</p> </li> <li> <p>Specific adverse events, particularly somnolence, dizziness, and weight gain.</p> </li> </ol> </p> <p>These outcomes were not eligibility criteria for this review, but outcomes of interest within the included studies. </p> </section> </section> </section> <section id="CD010769-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010769-sec-0045"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases:</p> <p> <ul id="CD010769-list-0005"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) (in <i>The Cochrane Library</i>, 2013, Issue 11 of 12). </p> </li> <li> <p>MEDLINE (via Ovid), January 2009 to 18 November 2013.</p> </li> <li> <p>EMBASE (via Ovid), January 2009 to 18 November 2013.</p> </li> </ul> </p> <p>The search strategies for CENTRAL, MEDLINE, and EMBASE are in <a href="./appendices#CD010769-sec-0091">Appendix 2</a>, <a href="./appendices#CD010769-sec-0092">Appendix 3</a>, and <a href="./appendices#CD010769-sec-0093">Appendix 4</a>, respectively. There were no language restrictions. </p> </section> <section id="CD010769-sec-0046"> <h4 class="title">Searching other resources</h4> <p>We searched our own hand‐searched database for older studies and two clinical trials databases (<a href="http://ClinicalTrials.gov" target="_blank">ClinicalTrials.gov</a> and the World Health Organisation (WHO) International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>)), together with the reference lists of included studies and relevant review articles. We did not contact investigators or study sponsors. </p> </section> </section> <section id="CD010769-sec-0047"> <h3 class="title" id="CD010769-sec-0047">Data collection and analysis</h3> <p>The intention was to perform separate analyses according to particular neuropathic pain conditions. Analyses combining different neuropathic pain conditions would be done for exploratory purposes only. </p> <section id="CD010769-sec-0048"> <h4 class="title">Selection of studies</h4> <p>We determined eligibility by reading the title and abstract of each study identified by the search. We eliminated studies that clearly did not satisfy inclusion criteria, and obtained full copies of the remaining studies; decisions were made by two review authors. Two review authors read these studies independently and reached agreement by discussion. We did not anonymise the studies in any way before assessment. </p> </section> <section id="CD010769-sec-0049"> <h4 class="title">Data extraction and management</h4> <p>Two review authors independently extracted data using a standard form and checked for agreement before entry into RevMan (<a href="./references#CD010769-bbs2-0060" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>) or any other analysis tool. We included information about the pain condition and number of participants treated, drug and dosing regimen, study design (placebo or active control), study duration and follow‐up, analgesic outcome measures and results, withdrawals and adverse events (participants experiencing any adverse event or serious adverse event). </p> </section> <section id="CD010769-sec-0050"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We used the Oxford Quality Score (<a href="./references#CD010769-bbs2-0025" title="JadadAR , MooreRA , CarrollD , JenkinsonC , ReynoldsDJ , GavaghanDJ , et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials1996;17(1):1‐12. [DOI: doi.org/10.1016/0197‐2456(95)00134‐4] ">Jadad 1996</a>) as the basis for inclusion, limiting inclusion to studies that were, as a minimum, randomised and double‐blind. </p> <p>Two review authors independently assessed risk of bias for each study, using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010769-bbs2-0024" title="HigginsJPT , GreenS (editors) . Chapter 8: Assessing risk of bias in included studies. In: HigginsJPT , AltmanDG , SterneJAC editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) and adapted from those used by the Cochrane Pregnancy and Childbirth Group, with any disagreements resolved by discussion. </p> <p> <ol id="CD010769-list-0006"> <li> <p>We assessed the following for each study: Random sequence generation (checking for possible selection bias). We assessed the method used to generate the allocation sequence as: low risk of bias (any truly random process, for example random number table; computer random number generator); unclear risk of bias (method used to generate sequence not clearly stated). We excluded studies using a non‐random process (for example, odd or even date of birth; hospital or clinic record number). </p> </li> <li> <p>Allocation concealment (checking for possible selection bias). The method used to conceal allocation to interventions prior to assignment determines whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. We assessed the methods as: low risk of bias (for example, telephone or central randomisation; consecutively numbered sealed opaque envelopes); unclear risk of bias (method not clearly stated). We excluded studies that did not conceal allocation (for example, open list). </p> </li> <li> <p>Blinding of outcome assessment (checking for possible detection bias). We assessed the methods used to blind study participants and outcome assessors from knowledge of which intervention a participant received. We assessed the methods as: low risk of bias (study stated that it was blinded and described the method used to achieve blinding, for example, identical tablets; matched in appearance and smell); unclear risk of bias (study stated that it was blinded but did not provide an adequate description of how it was achieved). We excluded studies that were not double‐blind. </p> </li> <li> <p>Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data). We assessed the methods used to deal with incomplete data as: low risk (&lt; 10% of participants did not complete the study or used ‘baseline observation carried forward’ analysis, or both); unclear risk of bias (used 'last observation carried forward' analysis); high risk of bias (used 'completer' analysis). </p> </li> <li> <p>Size of study (checking for possible biases confounded by small size). We assessed studies as being at low risk of bias (≥ 200 participants per treatment arm); unclear risk of bias (50 to 199 participants per treatment arm); high risk of bias (&lt; 50 participants per treatment arm). </p> </li> </ol> </p> </section> <section id="CD010769-sec-0051"> <h4 class="title">Measures of treatment effect</h4> <p>We planned to calculate NNTs as the reciprocal of the absolute risk reduction (ARR) (<a href="./references#CD010769-bbs2-0033" title="McQuayH , MooreR . An evidence‐based resource for pain relief. Oxford: Oxford University Press, 1998. ">McQuay 1998</a>). For unwanted effects, the NNT becomes the number needed to treat for an additional harmful outcome (NNH) and is calculated in the same manner. We planned to use dichotomous data to calculate risk ratio (RR) with 95% confidence intervals (CI) using a fixed‐effect model unless significant statistical heterogeneity was found (see below). Continuous data were not used in analyses. </p> </section> <section id="CD010769-sec-0052"> <h4 class="title">Unit of analysis issues</h4> <p>We accepted randomisation to individual participants only.</p> <p>For cross‐over studies, we planned to use only the first period, if this was available. Where only combined data for both periods were reported, we treated the study as if it was a parallel study, drawing attention to the potential bias that this confers, and interpreting the results accordingly. </p> </section> <section id="CD010769-sec-0053"> <h4 class="title">Dealing with missing data</h4> <p>We planned to use intention‐to‐treat (ITT) analysis, where the ITT population consisted of participants who were randomised, took at least one dose of the assigned study medication, and provided at least one post‐baseline assessment. Missing participants would be assigned zero improvement. </p> <p>Where only mean data were reported, using a completer analysis or with uncertain imputation methods, we have reported the results and drawn attention to potential biases. These data were not used in any analyses. </p> </section> <section id="CD010769-sec-0054"> <h4 class="title">Assessment of heterogeneity</h4> <p>We planned to deal with clinical heterogeneity by combining studies that examined similar conditions, and assess statistical heterogeneity visually (<a href="./references#CD010769-bbs2-0031" title="L'AbbéKA , DetskyAS , O'RourkeK . Meta‐analysis in clinical research. Annals of Internal Medicine1987;107:224‐33. ">L'Abbé 1987</a>) and with the use of the I² statistic. </p> </section> <section id="CD010769-sec-0055"> <h4 class="title">Assessment of reporting biases</h4> <p>The aim of this review was to use dichotomous data of known utility (<a href="./references#CD010769-bbs2-0042" title="MooreRA , StraubeS , PaineJ , PhillipsCJ , DerryS , McQuayHJ . Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain. Pain2010;149(2):360‐4. [DOI: 10.1016/j.pain.2010.02.039] ">Moore 2010c</a>). The review did not depend on what authors of the original studies chose to report or not, although clearly difficulties arose in studies failing to report any dichotomous results. We have extracted and reported continuous data, which probably poorly reflect efficacy and utility, where useful, for illustrative purposes only. </p> <p>We planned to assess publication bias using a method designed to detect the amount of unpublished data with a null effect required to make any result clinically irrelevant (usually taken to mean an NNT of 10 or higher) (<a href="./references#CD010769-bbs2-0037" title="MooreRA , BardenJ , DerryS , McQuayHJ . Managing potential publication bias. In: McQuayHJ , KalsoE , MooreRA editor(s). Systematic Reviews in Pain Research: Methodology Refined. Seattle: IASP Press, 2008:15‐24. [ISBN: 978–0–931092–69–5] ">Moore 2008</a>). </p> </section> <section id="CD010769-sec-0056"> <h4 class="title">Data synthesis</h4> <p>We planned to use a fixed‐effect model for meta‐analysis, or use a random‐effects model if there was significant clinical heterogeneity and it was considered appropriate to combine studies. </p> <p>We analysed data for each painful condition in three tiers, according to outcome and freedom from known sources of bias. </p> <p> <ul id="CD010769-list-0007"> <li> <p>The first tier uses data meeting current best standards, where studies report the outcome of at least 50% pain intensity reduction over baseline (or its equivalent), without the use of last observation carried forward (LOCF) or other imputation method for dropouts, report an ITT analysis, last eight or more weeks, have a parallel group design, and have at least 200 participants (preferably at least 400) in the comparison (<a href="./references#CD010769-bbs2-0040" title='MooreRA , EcclestonC , DerryS , WiffenP , BellRF , StraubeS , et al. "Evidence" in chronic pain ‐ establishing best practice in the reporting of systematic reviews. Pain2010;150(3):386‐9. [DOI: doi:10.1016/j.pain.2010.05.011] '>Moore 2010a</a>; <a href="./references#CD010769-bbs2-0049" title="MooreRA , StraubeS , EcclestonC , DerryS , AldingtonD , WiffenP , et al. Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses. Pain2012;153(2):265‐8. [DOI: 10.1016/j.pain.2011.10.004] ">Moore 2012b</a>). These top tier results are reported first. </p> </li> <li> <p>The second tier uses data from at least 200 participants but where one or more of the above conditions is not met (for example reporting at least 30% pain intensity reduction, using LOCF or a completer analysis, or lasting four to eight weeks). </p> </li> <li> <p>The third tier of evidence relates to data from fewer than 200 participants, or where there are expected to be significant problems because, for example, of very short duration studies of less than four weeks, where there is major heterogeneity between studies, or where there are shortcomings in allocation concealment, attrition, or incomplete outcome data. For this third tier of evidence, no data synthesis is reasonable, and may be misleading, but an indication of beneficial effects might be possible. </p> </li> </ul> </p> </section> <section id="CD010769-sec-0057"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to carry out all analyses according to individual painful conditions because placebo response rates with the same outcome can vary between conditions, as can drug‐specific effects (<a href="./references#CD010769-bbs2-0038" title="MooreRA , StraubeS , WiffenPJ , DerryS , McQuayHJ . Pregabalin for acute and chronic pain in adults. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD007076.pub2] ">Moore 2009a</a>). </p> </section> <section id="CD010769-sec-0058"> <h4 class="title">Sensitivity analysis</h4> <p>We did not plan any sensitivity analysis because the evidence base was known to be too small to allow reliable analysis. We would have examined details of dose escalation schedules if we had felt it could provide some basis for a sensitivity analysis. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010769-sec-0059" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010769-sec-0059"></div> <section id="CD010769-sec-0060"> <h3 class="title">Description of studies</h3> <section id="CD010769-sec-0061"> <h4 class="title">Results of the search</h4> <p>Searches found fewer than 100 titles that we examined for inclusion. After screening titles and abstracts, we obtained full copies and examined 11 reports in detail. We included five studies (six reports; one study was published both in English and in Danish (<a href="./references#CD010769-bbs2-0001" title="KvinesdalB , MolinJ , FrolandA , GramLF . Imipramine in the treatment of painful diabetic neuropathy of the extremities [Imipramin ved behandling af smerter ved diabetisk ekstremitetsneuropati]. Ugeskrift for Laeger1983;145(39):3018‐9. KvinesdalB , MolinJ , FrolandA , GramLF . Imipramine treatment for painful diabetic neuropathy. Journal American Medical Association1984;251(13):1727‐30. ">Kvinesdal 1984</a>)) and excluded five studies (<a href="#CD010769-fig-0001">Figure 1</a>). We did not identify any new studies that were not in the earlier review (<a href="./references#CD010769-bbs2-0070" title="SaartoT , WiffenPJ . Antidepressants for neuropathic pain. Cochrane Database of Systematic Reviews2007, Issue 4. [DOI: 10.1002/14651858.CD005454.pub2] ">Saarto 2007</a>), but we excluded one study that was in the earlier version because it enrolled fewer than 10 participants per treatment arm (<a href="./references#CD010769-bbs2-0009" title="SindrupSH , EjlertsenB , FrolandA , SindrupEH , BrosenK , GramLF . Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve function. European Journal of Clinical Pharmacology1989;37:151‐3. ">Sindrup 1989</a>). </p> <div class="figure" id="CD010769-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Flow diagram." data-id="CD010769-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010769.pub2/media/CDSR/CD010769/image_n/nCD010769-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Flow diagram.</p> </div> </div> </div> </section> <section id="CD010769-sec-0062"> <h4 class="title">Included studies</h4> <p>Five studies treated 168 participants, of whom 126 were randomised to imipramine (<a href="./references#CD010769-bbs2-0001" title="KvinesdalB , MolinJ , FrolandA , GramLF . Imipramine in the treatment of painful diabetic neuropathy of the extremities [Imipramin ved behandling af smerter ved diabetisk ekstremitetsneuropati]. Ugeskrift for Laeger1983;145(39):3018‐9. KvinesdalB , MolinJ , FrolandA , GramLF . Imipramine treatment for painful diabetic neuropathy. Journal American Medical Association1984;251(13):1727‐30. ">Kvinesdal 1984</a>; <a href="./references#CD010769-bbs2-0002" title="SindrupSH , GramLF , BrosenK , EshojO , MogensenEF . The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain1990;42:135‐44. ">Sindrup 1990</a>; <a href="./references#CD010769-bbs2-0003" title="SindrupSH , TuxenC , GramLF , GrodumE , SkjoldT , BrosenK , Beck‐NielsenH . Lack of effect of mianserin on the symptoms of diabetic neuropathy. European Journal of Clinical Pharmacology1992;43:251‐5. ">Sindrup 1992</a>; <a href="./references#CD010769-bbs2-0004" title="SindrupSH , BachFW , MadsenC , et al. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology2003;60:1284‐9. ">Sindrup 2003</a>; <a href="./references#CD010769-bbs2-0005" title="TurkingtonRW . Depression masquerading as diabetic neuropathy. Journal American Medical Association1980;243(11):1147‐50. ">Turkington 1980</a>); in the cross‐over studies, however, it was not clear whether all randomised participants received all treatments, and most studies did not report results for all randomised participants. Two studies included an imipramine dose‐finding phase (<a href="./references#CD010769-bbs2-0002" title="SindrupSH , GramLF , BrosenK , EshojO , MogensenEF . The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain1990;42:135‐44. ">Sindrup 1990</a>; <a href="./references#CD010769-bbs2-0003" title="SindrupSH , TuxenC , GramLF , GrodumE , SkjoldT , BrosenK , Beck‐NielsenH . Lack of effect of mianserin on the symptoms of diabetic neuropathy. European Journal of Clinical Pharmacology1992;43:251‐5. ">Sindrup 1992</a>): in the first of these, 3 of 32 participants withdrew because of adverse events. Participants took oral imipramine for between 2 and 12 weeks. Daily doses were between 25 mg and 350 mg (mostly 100 mg to 150 mg). The licensed maximum dose is commonly 200 mg, except in hospitalised patients. Poor metabolisers were excluded or treated with the lowest doses. </p> <p>Study participants were aged between 20 and 75 years (study mean ages from 47 to 56 years) and there were approximately equal numbers of men and women, except in <a href="./references#CD010769-bbs2-0004" title="SindrupSH , BachFW , MadsenC , et al. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology2003;60:1284‐9. ">Sindrup 2003</a> (23 men, 9 women). Participants had experienced pain associated with diabetic neuropathy or painful polyneuropathy for at least six months. Common grounds for exclusion from studies were anaemia, renal or cardiac dysfunction, hypothyroidism, and amputation. </p> <p>Imipramine was compared with placebo (<a href="./references#CD010769-bbs2-0001" title="KvinesdalB , MolinJ , FrolandA , GramLF . Imipramine in the treatment of painful diabetic neuropathy of the extremities [Imipramin ved behandling af smerter ved diabetisk ekstremitetsneuropati]. Ugeskrift for Laeger1983;145(39):3018‐9. KvinesdalB , MolinJ , FrolandA , GramLF . Imipramine treatment for painful diabetic neuropathy. Journal American Medical Association1984;251(13):1727‐30. ">Kvinesdal 1984</a>; <a href="./references#CD010769-bbs2-0002" title="SindrupSH , GramLF , BrosenK , EshojO , MogensenEF . The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain1990;42:135‐44. ">Sindrup 1990</a>; <a href="./references#CD010769-bbs2-0003" title="SindrupSH , TuxenC , GramLF , GrodumE , SkjoldT , BrosenK , Beck‐NielsenH . Lack of effect of mianserin on the symptoms of diabetic neuropathy. European Journal of Clinical Pharmacology1992;43:251‐5. ">Sindrup 1992</a>; <a href="./references#CD010769-bbs2-0004" title="SindrupSH , BachFW , MadsenC , et al. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology2003;60:1284‐9. ">Sindrup 2003</a>) or active placebo (diazepam (19 participants in parallel arm) <a href="./references#CD010769-bbs2-0005" title="TurkingtonRW . Depression masquerading as diabetic neuropathy. Journal American Medical Association1980;243(11):1147‐50. ">Turkington 1980</a>). </p> <p>In four studies, another analgesic was compared with imipramine: paroxetine (22 participants, <a href="./references#CD010769-bbs2-0002" title="SindrupSH , GramLF , BrosenK , EshojO , MogensenEF . The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain1990;42:135‐44. ">Sindrup 1990</a>), mianserin (22 participants, <a href="./references#CD010769-bbs2-0003" title="SindrupSH , TuxenC , GramLF , GrodumE , SkjoldT , BrosenK , Beck‐NielsenH . Lack of effect of mianserin on the symptoms of diabetic neuropathy. European Journal of Clinical Pharmacology1992;43:251‐5. ">Sindrup 1992</a>), venlafaxine (40 participants, <a href="./references#CD010769-bbs2-0004" title="SindrupSH , BachFW , MadsenC , et al. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology2003;60:1284‐9. ">Sindrup 2003</a>), and amitriptyline (20 participants, <a href="./references#CD010769-bbs2-0005" title="TurkingtonRW . Depression masquerading as diabetic neuropathy. Journal American Medical Association1980;243(11):1147‐50. ">Turkington 1980</a>). </p> <p>One study used a parallel group design (<a href="./references#CD010769-bbs2-0005" title="TurkingtonRW . Depression masquerading as diabetic neuropathy. Journal American Medical Association1980;243(11):1147‐50. ">Turkington 1980</a>), and the other four used a cross‐over design (<a href="./references#CD010769-bbs2-0001" title="KvinesdalB , MolinJ , FrolandA , GramLF . Imipramine in the treatment of painful diabetic neuropathy of the extremities [Imipramin ved behandling af smerter ved diabetisk ekstremitetsneuropati]. Ugeskrift for Laeger1983;145(39):3018‐9. KvinesdalB , MolinJ , FrolandA , GramLF . Imipramine treatment for painful diabetic neuropathy. Journal American Medical Association1984;251(13):1727‐30. ">Kvinesdal 1984</a>; <a href="./references#CD010769-bbs2-0002" title="SindrupSH , GramLF , BrosenK , EshojO , MogensenEF . The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain1990;42:135‐44. ">Sindrup 1990</a>; <a href="./references#CD010769-bbs2-0003" title="SindrupSH , TuxenC , GramLF , GrodumE , SkjoldT , BrosenK , Beck‐NielsenH . Lack of effect of mianserin on the symptoms of diabetic neuropathy. European Journal of Clinical Pharmacology1992;43:251‐5. ">Sindrup 1992</a>; <a href="./references#CD010769-bbs2-0004" title="SindrupSH , BachFW , MadsenC , et al. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology2003;60:1284‐9. ">Sindrup 2003</a>). </p> <p>Two studies had washout periods before or between cross‐over periods (<a href="./references#CD010769-bbs2-0003" title="SindrupSH , TuxenC , GramLF , GrodumE , SkjoldT , BrosenK , Beck‐NielsenH . Lack of effect of mianserin on the symptoms of diabetic neuropathy. European Journal of Clinical Pharmacology1992;43:251‐5. ">Sindrup 1992</a>; <a href="./references#CD010769-bbs2-0004" title="SindrupSH , BachFW , MadsenC , et al. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology2003;60:1284‐9. ">Sindrup 2003</a>), and two gave imipramine in a dose‐finding phase (<a href="./references#CD010769-bbs2-0002" title="SindrupSH , GramLF , BrosenK , EshojO , MogensenEF . The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain1990;42:135‐44. ">Sindrup 1990</a>; <a href="./references#CD010769-bbs2-0003" title="SindrupSH , TuxenC , GramLF , GrodumE , SkjoldT , BrosenK , Beck‐NielsenH . Lack of effect of mianserin on the symptoms of diabetic neuropathy. European Journal of Clinical Pharmacology1992;43:251‐5. ">Sindrup 1992</a>). Stable medication for diabetes was maintained. </p> <p>No included studies involved any other type of neuropathic pain.</p> </section> <section id="CD010769-sec-0063"> <h4 class="title">Excluded studies</h4> <p>We excluded five studies after reading the full papers. <a href="./references#CD010769-bbs2-0009" title="SindrupSH , EjlertsenB , FrolandA , SindrupEH , BrosenK , GramLF . Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve function. European Journal of Clinical Pharmacology1989;37:151‐3. ">Sindrup 1989</a> had fewer than 10 participants, <a href="./references#CD010769-bbs2-0006" title="KvinesdalB , MolinJ , FrølandA , GramLF . Antidepressive agents in the treatment of diabetic neuropathy. Clinical Physiology1985;5 (Suppl):97‐100. ">Kvinesdal 1985</a>, <a href="./references#CD010769-bbs2-0008" title="RasmussenPV , JensenTS , SindrupSH , BachFW . TDM‐based imipramine treatment in neuropathic pain. Ther Drug Monit2004;26(4):352‐60. ">Rasmussen 2004</a>, and <a href="./references#CD010769-bbs2-0010" title="WysebeekAJ , MorF , LurieY , WeinbergerA . Imipramine for the treatment of fibrositis: a therapeutic trial. Annals of the Rheumatic Diseases1985;44:752‐3. ">Wysenbeek 1985</a> were not RCTs, and <a href="./references#CD010769-bbs2-0007" title="MinottiV , DeAngelisV , RighettiE , CelaniMG , et al. Double‐blind evaluation of short‐term analgesic efficacy of orally administered diclofenac, diclofenac plus codeine, and diclofenac plus imipramine in chronic cancer pain. Pain1998;74:133‐7. ">Minotti 1998</a> described imipramine as an "add‐on" to diclofenac treatment. </p> </section> </section> <section id="CD010769-sec-0064"> <h3 class="title">Risk of bias in included studies</h3> <p>Comments on potential biases in individual studies are reported in the Risk of bias section of the <a href="./references#CD010769-sec-0105" title="">Characteristics of included studies</a> table. The findings are displayed in <a href="#CD010769-fig-0002">Figure 2</a> and <a href="#CD010769-fig-0003">Figure 3</a>; no sensitivity analysis was undertaken. The greatest risk of bias was associated with small study size. </p> <div class="figure" id="CD010769-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010769-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010769.pub2/media/CDSR/CD010769/image_n/nCD010769-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD010769-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010769-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010769.pub2/media/CDSR/CD010769/image_n/nCD010769-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD010769-sec-0065"> <h4 class="title">Allocation</h4> <p>All studies were randomised. Only <a href="./references#CD010769-bbs2-0004" title="SindrupSH , BachFW , MadsenC , et al. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology2003;60:1284‐9. ">Sindrup 2003</a> adequately described how allocation to treatment groups was concealed; the others did not report this. </p> </section> <section id="CD010769-sec-0066"> <h4 class="title">Blinding</h4> <p>All studies were double blind. Four studies (<a href="./references#CD010769-bbs2-0001" title="KvinesdalB , MolinJ , FrolandA , GramLF . Imipramine in the treatment of painful diabetic neuropathy of the extremities [Imipramin ved behandling af smerter ved diabetisk ekstremitetsneuropati]. Ugeskrift for Laeger1983;145(39):3018‐9. KvinesdalB , MolinJ , FrolandA , GramLF . Imipramine treatment for painful diabetic neuropathy. Journal American Medical Association1984;251(13):1727‐30. ">Kvinesdal 1984</a>; <a href="./references#CD010769-bbs2-0002" title="SindrupSH , GramLF , BrosenK , EshojO , MogensenEF . The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain1990;42:135‐44. ">Sindrup 1990</a>; <a href="./references#CD010769-bbs2-0003" title="SindrupSH , TuxenC , GramLF , GrodumE , SkjoldT , BrosenK , Beck‐NielsenH . Lack of effect of mianserin on the symptoms of diabetic neuropathy. European Journal of Clinical Pharmacology1992;43:251‐5. ">Sindrup 1992</a>; <a href="./references#CD010769-bbs2-0004" title="SindrupSH , BachFW , MadsenC , et al. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology2003;60:1284‐9. ">Sindrup 2003</a>) adequately described the methods used to ensure that participants and interacting investigators were unable to differentiate between active and control groups; <a href="./references#CD010769-bbs2-0005" title="TurkingtonRW . Depression masquerading as diabetic neuropathy. Journal American Medical Association1980;243(11):1147‐50. ">Turkington 1980</a> did not discuss this. </p> </section> <section id="CD010769-sec-0067"> <h4 class="title">Incomplete outcome data</h4> <p><a href="./references#CD010769-bbs2-0005" title="TurkingtonRW . Depression masquerading as diabetic neuropathy. Journal American Medical Association1980;243(11):1147‐50. ">Turkington 1980</a> reported no withdrawals or losses to follow‐up. The remaining studies (<a href="./references#CD010769-bbs2-0001" title="KvinesdalB , MolinJ , FrolandA , GramLF . Imipramine in the treatment of painful diabetic neuropathy of the extremities [Imipramin ved behandling af smerter ved diabetisk ekstremitetsneuropati]. Ugeskrift for Laeger1983;145(39):3018‐9. KvinesdalB , MolinJ , FrolandA , GramLF . Imipramine treatment for painful diabetic neuropathy. Journal American Medical Association1984;251(13):1727‐30. ">Kvinesdal 1984</a>; <a href="./references#CD010769-bbs2-0002" title="SindrupSH , GramLF , BrosenK , EshojO , MogensenEF . The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain1990;42:135‐44. ">Sindrup 1990</a>; <a href="./references#CD010769-bbs2-0003" title="SindrupSH , TuxenC , GramLF , GrodumE , SkjoldT , BrosenK , Beck‐NielsenH . Lack of effect of mianserin on the symptoms of diabetic neuropathy. European Journal of Clinical Pharmacology1992;43:251‐5. ">Sindrup 1992</a>; <a href="./references#CD010769-bbs2-0004" title="SindrupSH , BachFW , MadsenC , et al. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology2003;60:1284‐9. ">Sindrup 2003</a>) performed efficacy analyses only on those participants who completed the study (completer analyses). Proportions of withdrawals were relatively high: 3/15 (<a href="./references#CD010769-bbs2-0001" title="KvinesdalB , MolinJ , FrolandA , GramLF . Imipramine in the treatment of painful diabetic neuropathy of the extremities [Imipramin ved behandling af smerter ved diabetisk ekstremitetsneuropati]. Ugeskrift for Laeger1983;145(39):3018‐9. KvinesdalB , MolinJ , FrolandA , GramLF . Imipramine treatment for painful diabetic neuropathy. Journal American Medical Association1984;251(13):1727‐30. ">Kvinesdal 1984)</a>, 10/29 (<a href="./references#CD010769-bbs2-0002" title="SindrupSH , GramLF , BrosenK , EshojO , MogensenEF . The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain1990;42:135‐44. ">Sindrup 1990</a>), 4/22 (<a href="./references#CD010769-bbs2-0003" title="SindrupSH , TuxenC , GramLF , GrodumE , SkjoldT , BrosenK , Beck‐NielsenH . Lack of effect of mianserin on the symptoms of diabetic neuropathy. European Journal of Clinical Pharmacology1992;43:251‐5. ">Sindrup 1992</a>), 8/40 (<a href="./references#CD010769-bbs2-0004" title="SindrupSH , BachFW , MadsenC , et al. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology2003;60:1284‐9. ">Sindrup 2003</a>). </p> <p>Missing participants can sometimes be added back in (analysed as non‐responders) for dichotomous outcomes, but this is not possible when mean data are reported. </p> </section> <section id="CD010769-sec-0068"> <h4 class="title">Selective reporting</h4> <p>All studies reported the outcomes specified in the methods but these were not usually our preferred (primary) outcomes. Pain was not reported separately in <a href="./references#CD010769-bbs2-0001" title="KvinesdalB , MolinJ , FrolandA , GramLF . Imipramine in the treatment of painful diabetic neuropathy of the extremities [Imipramin ved behandling af smerter ved diabetisk ekstremitetsneuropati]. Ugeskrift for Laeger1983;145(39):3018‐9. KvinesdalB , MolinJ , FrolandA , GramLF . Imipramine treatment for painful diabetic neuropathy. Journal American Medical Association1984;251(13):1727‐30. ">Kvinesdal 1984</a>, <a href="./references#CD010769-bbs2-0002" title="SindrupSH , GramLF , BrosenK , EshojO , MogensenEF . The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain1990;42:135‐44. ">Sindrup 1990</a>, <a href="./references#CD010769-bbs2-0003" title="SindrupSH , TuxenC , GramLF , GrodumE , SkjoldT , BrosenK , Beck‐NielsenH . Lack of effect of mianserin on the symptoms of diabetic neuropathy. European Journal of Clinical Pharmacology1992;43:251‐5. ">Sindrup 1992</a>. </p> </section> <section id="CD010769-sec-0069"> <h4 class="title">Other potential sources of bias</h4> <p>None of the studies randomised sufficient numbers of participants to minimise the bias associated with small studies (<a href="./references#CD010769-bbs2-0056" title="NüeschE , TrelleS , ReichenbachS , RutjesAW , TschannenB , AltmanDG , et al. Small study effects in meta‐analyses of osteoarthritis trials: meta‐epidemiological study. BMJ2010;341:c3515. [DOI: 10.1136/bmj.c3515] ">Nüesch 2010</a>). The greatest number randomised was 32 (<a href="./references#CD010769-bbs2-0004" title="SindrupSH , BachFW , MadsenC , et al. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology2003;60:1284‐9. ">Sindrup 2003</a>) so the risk of bias is high. </p> </section> </section> <section id="CD010769-sec-0070"> <h3 class="title" id="CD010769-sec-0070">Effects of interventions</h3> <p>See: <a href="./full#CD010769-tbl-0001"><b>Summary of findings for the main comparison</b> </a> </p> <section id="CD010769-sec-0071"> <h4 class="title">Efficacy</h4> <p>We found no first or second tier evidence of efficacy. Evidence was downgraded primarily because of the short duration of the studies, small numbers of participants in comparisons, reporting of completer analyses in cross‐over studies, and lack of desirable primary outcomes. </p> <p>Four studies reported at least one pain‐related outcome indicating some improvement with imipramine compared with placebo. Three studies (<a href="./references#CD010769-bbs2-0001" title="KvinesdalB , MolinJ , FrolandA , GramLF . Imipramine in the treatment of painful diabetic neuropathy of the extremities [Imipramin ved behandling af smerter ved diabetisk ekstremitetsneuropati]. Ugeskrift for Laeger1983;145(39):3018‐9. KvinesdalB , MolinJ , FrolandA , GramLF . Imipramine treatment for painful diabetic neuropathy. Journal American Medical Association1984;251(13):1727‐30. ">Kvinesdal 1984</a>; <a href="./references#CD010769-bbs2-0002" title="SindrupSH , GramLF , BrosenK , EshojO , MogensenEF . The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain1990;42:135‐44. ">Sindrup 1990</a>; <a href="./references#CD010769-bbs2-0003" title="SindrupSH , TuxenC , GramLF , GrodumE , SkjoldT , BrosenK , Beck‐NielsenH . Lack of effect of mianserin on the symptoms of diabetic neuropathy. European Journal of Clinical Pharmacology1992;43:251‐5. ">Sindrup 1992</a>) reported improvement on a set of neuropathy symptoms, which included pain, but only one (<a href="./references#CD010769-bbs2-0002" title="SindrupSH , GramLF , BrosenK , EshojO , MogensenEF . The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain1990;42:135‐44. ">Sindrup 1990</a>) reported the pain item separately (as group median scores). Details of data from individual studies are shown in <a href="./appendices#CD010769-sec-0094">Appendix 5</a>. </p> <p><b>Third tier evidence</b> </p> <p><a href="./references#CD010769-bbs2-0001" title="KvinesdalB , MolinJ , FrolandA , GramLF . Imipramine in the treatment of painful diabetic neuropathy of the extremities [Imipramin ved behandling af smerter ved diabetisk ekstremitetsneuropati]. Ugeskrift for Laeger1983;145(39):3018‐9. KvinesdalB , MolinJ , FrolandA , GramLF . Imipramine treatment for painful diabetic neuropathy. Journal American Medical Association1984;251(13):1727‐30. ">Kvinesdal 1984</a> assessed six symptoms (pain, dysaesthesia, paraesthesia, numbness, nightly aggravation, and sleep disturbances) which were combined to give a neuropathy symptom score; pain was not reported separately. The authors reported that 8/12 participants who completed both phases of the cross‐over (ITT 8/15) assessed their condition as "improved" (undefined) with imipramine 100 mg daily, compared with 1/12 (ITT 1/15) with placebo. </p> <p>In <a href="./references#CD010769-bbs2-0002" title="SindrupSH , GramLF , BrosenK , EshojO , MogensenEF . The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain1990;42:135‐44. ">Sindrup 1990</a>, pain was not reported separately but only as part of a set of neuropathy symptoms. </p> <p>Participants' median VAS scores for pain shown on a graph indicated about an 80% reduction in pain rating at the end of the treatment period from baseline or placebo for those who completed all phases of the cross‐over. Participants with at least 50% reduction, compared with placebo, in combined VAS scores for five symptoms (pain, paraesthesia, dysaesthesia, nightly aggravation, and sleep disturbances) with imipramine 25 mg to 350 mg daily, numbered 12/19 for completers (ITT 12/29). For at least 30% reduction, the number was 14/19 for completers (ITT 14/29). </p> <p><a href="./references#CD010769-bbs2-0003" title="SindrupSH , TuxenC , GramLF , GrodumE , SkjoldT , BrosenK , Beck‐NielsenH . Lack of effect of mianserin on the symptoms of diabetic neuropathy. European Journal of Clinical Pharmacology1992;43:251‐5. ">Sindrup 1992</a> also reported a combined set of neuropathy symptoms (pain, paraesthesiae, dysaesthesiae, numbness, nightly exacerbation, and sleep disturbance) assessed by both participants and observers. Participants reporting at least 50% reduction in symptoms with imipramine 25 mg to 350 mg (median 150 mg) daily totaled 3/18 for those who completed all phases of the cross‐over (ITT 3/22), with 9/18 completers (ITT 9/22) reporting at least 30% reduction, both figures relative to placebo. The relevant figures for mianserin were 3/18 and 5/18, respectively. </p> <p><a href="./references#CD010769-bbs2-0004" title="SindrupSH , BachFW , MadsenC , et al. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology2003;60:1284‐9. ">Sindrup 2003</a> reported participants' ratings for several types of pain (pain paroxysms, constant pain, touch‐evoked pain, pressure‐evoked pain). These were reduced by 29%, 29%, 4%, and 20%, respectively, for completers with imipramine up to 150 mg daily. An overall reduction of 23% from baseline is quoted. </p> <p>Participants' global evaluation of pain relief (complete, good, moderate, slight, none, worse) was complete or good for 9/29 with imipramine in those who completed all phases of the cross‐over (ITT 9/40), 7/30 with venlafaxine (ITT 7/40), and 2/29 with placebo (ITT 2/40). For an evaluation of complete, good, or moderate, the numbers were 14/29 with imipramine (ITT 14/40), 8/30 with venlafaxine (ITT 8/40), and 2/29 with placebo (ITT 2/40). A subgroup analysis indicated that the subgroup of participants with diabetic neuropathy were more likely to obtain clinically relevant pain relief. </p> <p>The study authors report an NNT of 2.7 for &gt; 50% pain relief, but do not report the raw data on which this calculation was based, or any confidence intervals. We believe it may be based on a completer analysis of participants giving complete, good, or moderate global evaluations of pain relief, which we would consider to be closer to ≥ 30% pain relief. </p> <p><a href="./references#CD010769-bbs2-0005" title="TurkingtonRW . Depression masquerading as diabetic neuropathy. Journal American Medical Association1980;243(11):1147‐50. ">Turkington 1980</a> reported complete (100%) pain relief with imipramine 100 mg daily (20/20 completers and ITT) and no relief with placebo (0/20 completers and ITT). </p> </section> <section id="CD010769-sec-0072"> <h4 class="title">Adverse events</h4> <p>Details of adverse events reported in individual studies are in <a href="./appendices#CD010769-sec-0095">Appendix 6</a>. Four studies (<a href="./references#CD010769-bbs2-0001" title="KvinesdalB , MolinJ , FrolandA , GramLF . Imipramine in the treatment of painful diabetic neuropathy of the extremities [Imipramin ved behandling af smerter ved diabetisk ekstremitetsneuropati]. Ugeskrift for Laeger1983;145(39):3018‐9. KvinesdalB , MolinJ , FrolandA , GramLF . Imipramine treatment for painful diabetic neuropathy. Journal American Medical Association1984;251(13):1727‐30. ">Kvinesdal 1984</a>; <a href="./references#CD010769-bbs2-0002" title="SindrupSH , GramLF , BrosenK , EshojO , MogensenEF . The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain1990;42:135‐44. ">Sindrup 1990</a>; <a href="./references#CD010769-bbs2-0003" title="SindrupSH , TuxenC , GramLF , GrodumE , SkjoldT , BrosenK , Beck‐NielsenH . Lack of effect of mianserin on the symptoms of diabetic neuropathy. European Journal of Clinical Pharmacology1992;43:251‐5. ">Sindrup 1992</a>; <a href="./references#CD010769-bbs2-0004" title="SindrupSH , BachFW , MadsenC , et al. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology2003;60:1284‐9. ">Sindrup 2003</a>) reported some information about adverse events, but reporting was inconsistent and fragmented; the remaining study (<a href="./references#CD010769-bbs2-0005" title="TurkingtonRW . Depression masquerading as diabetic neuropathy. Journal American Medical Association1980;243(11):1147‐50. ">Turkington 1980</a>) did not mention adverse events. </p> <section id="CD010769-sec-0073"> <h5 class="title">Participants experiencing any adverse event</h5> <p>No study adequately reported the number of participants who experienced one or more adverse events for all those who were treated (ITT). </p> <p><a href="./references#CD010769-bbs2-0001" title="KvinesdalB , MolinJ , FrolandA , GramLF . Imipramine in the treatment of painful diabetic neuropathy of the extremities [Imipramin ved behandling af smerter ved diabetisk ekstremitetsneuropati]. Ugeskrift for Laeger1983;145(39):3018‐9. KvinesdalB , MolinJ , FrolandA , GramLF . Imipramine treatment for painful diabetic neuropathy. Journal American Medical Association1984;251(13):1727‐30. ">Kvinesdal 1984</a> reported that "side effects were generally few". Dry mouth was reported by 9/12 completers with imipramine and 1/12 with placebo, and impaired micturition was reported in two participants with imipramine, and dizziness in two participants, probably with imipramine. </p> <p><a href="./references#CD010769-bbs2-0002" title="SindrupSH , GramLF , BrosenK , EshojO , MogensenEF . The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain1990;42:135‐44. ">Sindrup 1990</a> asked participants to score the intensity of a range of adverse events using a VAS. Mean ratings for dry mouth, sweating, dizziness and fatigue were higher for imipramine than for placebo, but only dry mouth was notably higher. Frequencies of adverse events were not given except that 4/18 participants showed withdrawal symptoms (nausea, tremor, vomiting) after cessation of imipramine treatment. </p> <p><a href="./references#CD010769-bbs2-0003" title="SindrupSH , TuxenC , GramLF , GrodumE , SkjoldT , BrosenK , Beck‐NielsenH . Lack of effect of mianserin on the symptoms of diabetic neuropathy. European Journal of Clinical Pharmacology1992;43:251‐5. ">Sindrup 1992</a> asked participants to score the intensity of a number of adverse events on a scale of 0 to 2.0. The most common events were dry mouth, orthostatic dizziness, and fatigue. The total adverse events score was not significantly different between imipramine and mianserin, but scores for both active drugs were significantly higher than for placebo, with the total adverse event score for imipramine approximately four times that for placebo. Almost half (10/22) of participants experienced one or more adverse events during treatment with placebo. </p> <p><a href="./references#CD010769-bbs2-0004" title="SindrupSH , BachFW , MadsenC , et al. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology2003;60:1284‐9. ">Sindrup 2003</a> reported that of 29 participants completing all three treatment phases with valid results, 20 experienced an adverse event (of any intensity) with imipramine, 20 with venlafaxine, and 14 with placebo. At least one additional adverse event leading to withdrawal was reported with imipramine, four with venlafaxine, and two with placebo. </p> <p>There was a tendency for more adverse events with active treatment, particularly dry mouth with imipramine and tiredness with venlafaxine. Specific adverse events that were more common with imipramine than with placebo were as follows (in completers): dry mouth (12, 3); nausea (5, 1); sweating (5, 0); dizziness (3, 1); and blurred vision (1, 0). </p> <p><a href="./references#CD010769-bbs2-0005" title="TurkingtonRW . Depression masquerading as diabetic neuropathy. Journal American Medical Association1980;243(11):1147‐50. ">Turkington 1980</a> did not report any adverse events. </p> </section> <section id="CD010769-sec-0074"> <h5 class="title">Participants experiencing any serious adverse event</h5> <p>No study reported serious adverse events as such, although <a href="./references#CD010769-bbs2-0004" title="SindrupSH , BachFW , MadsenC , et al. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology2003;60:1284‐9. ">Sindrup 2003</a> reported that one participant had to drop out due to hospitalisation for a "pronounced" urinary tract infection (report does not state during which phase). </p> </section> </section> <section id="CD010769-sec-0075"> <h4 class="title">Withdrawals</h4> <p>Details of withdrawals reported in individual studies are provided in <a href="./appendices#CD010769-sec-0095">Appendix 6</a>. <a href="./references#CD010769-bbs2-0005" title="TurkingtonRW . Depression masquerading as diabetic neuropathy. Journal American Medical Association1980;243(11):1147‐50. ">Turkington 1980</a> did not report any withdrawals, so withdrawals are discussed only for participants in the other four studies. </p> <section id="CD010769-sec-0076"> <h5 class="title">Withdrawals due to adverse events</h5> <p>The remaining four studies reported withdrawals due to adverse events.</p> <p>Seven participants withdrew during treatment with imipramine, three during a dose‐finding phase (nausea, fatigue, dry mouth), and four (of 109) during a treatment phase. All four cited dizziness, in combination with, variously, orthostatic hypotension (1), tiredness (3), and vomiting (2). </p> <p>Three (of 109) dropped out during placebo treatment (gastritis, nausea/diarrhoea, vomiting), and four withdrew during venlafaxine treatment. </p> </section> <section id="CD010769-sec-0077"> <h5 class="title">Withdrawals due to lack of efficacy</h5> <p>There was only one withdrawal due to lack of efficacy reported during imipramine treatment (<a href="./references#CD010769-bbs2-0004" title="SindrupSH , BachFW , MadsenC , et al. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology2003;60:1284‐9. ">Sindrup 2003</a>) and none during placebo treatment. </p> </section> <section id="CD010769-sec-0078"> <h5 class="title">Withdrawals for other reasons</h5> <p>Three studies (69 participants) reported eight withdrawals for other reasons (<a href="./references#CD010769-bbs2-0001" title="KvinesdalB , MolinJ , FrolandA , GramLF . Imipramine in the treatment of painful diabetic neuropathy of the extremities [Imipramin ved behandling af smerter ved diabetisk ekstremitetsneuropati]. Ugeskrift for Laeger1983;145(39):3018‐9. KvinesdalB , MolinJ , FrolandA , GramLF . Imipramine treatment for painful diabetic neuropathy. Journal American Medical Association1984;251(13):1727‐30. ">Kvinesdal 1984</a>; <a href="./references#CD010769-bbs2-0002" title="SindrupSH , GramLF , BrosenK , EshojO , MogensenEF . The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain1990;42:135‐44. ">Sindrup 1990</a>; <a href="./references#CD010769-bbs2-0003" title="SindrupSH , TuxenC , GramLF , GrodumE , SkjoldT , BrosenK , Beck‐NielsenH . Lack of effect of mianserin on the symptoms of diabetic neuropathy. European Journal of Clinical Pharmacology1992;43:251‐5. ">Sindrup 1992</a>). </p> <p>During imipramine treatment, three participants withdrew for lack of compliance, two for personal reasons, and two because they needed analgesia for other pain. One from each of placebo and mianserin treatment groups withdrew for personal problems. </p> <p>Two participants were lost to follow‐up in <a href="./references#CD010769-bbs2-0004" title="SindrupSH , BachFW , MadsenC , et al. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology2003;60:1284‐9. ">Sindrup 2003</a> (treatment group was not specified). </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010769-sec-0079" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010769-sec-0079"></div> <section id="CD010769-sec-0080"> <h3 class="title" id="CD010769-sec-0080">Summary of main results</h3> <p>The review found five studies enrolling 168 participants with chronic neuropathic pain, 90% of whom had painful diabetic neuropathy and 10% had polyneuropathy of non‐diabetic origin. We did not identify any new studies but excluded one study that was included in an earlier review, because it enrolled fewer than 10 participants per treatment arm (<a href="./references#CD010769-bbs2-0009" title="SindrupSH , EjlertsenB , FrolandA , SindrupEH , BrosenK , GramLF . Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve function. European Journal of Clinical Pharmacology1989;37:151‐3. ">Sindrup 1989</a>). </p> <p>No first or second tier evidence was available. No pooling of data was possible, but third tier evidence in individual studies indicated some improvement in pain relief with imipramine compared with placebo, although this was very low grade evidence, derived mainly from group mean data and completer analyses (see <a href="./appendices#CD010769-sec-0090">Appendix 1</a>) in small, short duration studies in which major bias is possible. Four studies reported some information about adverse events, but reporting was inconsistent and fragmented. Participants taking imipramine generally experienced more adverse events, notably dry mouth, and a higher rate of withdrawal due to adverse events, compared with participants taking placebo. See <a href="./full#CD010769-tbl-0001">summary of findings Table for the main comparison</a>. </p> <p>More effective and safer medicines are available (<a href="./references#CD010769-bbs2-0032" title="LunnMP , HughesRA , WiffenPJ . Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database of Systematic Reviews2014, Issue 1. [DOI: 10.1002/14651858.CD007115.pub3] ">Lunn 2014</a>; <a href="./references#CD010769-bbs2-0038" title="MooreRA , StraubeS , WiffenPJ , DerryS , McQuayHJ . Pregabalin for acute and chronic pain in adults. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD007076.pub2] ">Moore 2009a</a>; <a href="./references#CD010769-bbs2-0045" title="MooreRA , WiffenPJ , DerryS , McQuayHJ . Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews2011, Issue 3. [DOI: 10.1002/14651858.CD007938.pub2] ">Moore 2011a</a>). </p> </section> <section id="CD010769-sec-0081"> <h3 class="title" id="CD010769-sec-0081">Overall completeness and applicability of evidence</h3> <p>Imipramine was tested only in painful neuropathy (primarily diabetic neuropathy), so results cannot be reliably extrapolated to other neuropathic conditions. Participants recruited into studies varied according to prevalence of depression and it is unclear whether this affected results. It is notable that <a href="./references#CD010769-bbs2-0005" title="TurkingtonRW . Depression masquerading as diabetic neuropathy. Journal American Medical Association1980;243(11):1147‐50. ">Turkington 1980</a> reported a remarkable effect on pain with imipramine given for three months to participants with depression; mean depression scores were more than halved in this group but unchanged in the placebo group. However, <a href="./references#CD010769-bbs2-0001" title="KvinesdalB , MolinJ , FrolandA , GramLF . Imipramine in the treatment of painful diabetic neuropathy of the extremities [Imipramin ved behandling af smerter ved diabetisk ekstremitetsneuropati]. Ugeskrift for Laeger1983;145(39):3018‐9. KvinesdalB , MolinJ , FrolandA , GramLF . Imipramine treatment for painful diabetic neuropathy. Journal American Medical Association1984;251(13):1727‐30. ">Kvinesdal 1984</a> and <a href="./references#CD010769-bbs2-0002" title="SindrupSH , GramLF , BrosenK , EshojO , MogensenEF . The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain1990;42:135‐44. ">Sindrup 1990</a> observed that none of their participants had any signs or symptoms of depression before or during treatment, but also experienced an effect on pain, albeit less marked. The other studies did not mention depression but perhaps this should have been measured at baseline, given the anti‐depressant action of imipramine. One study referred to the rapid onset of pain relief (<a href="./references#CD010769-bbs2-0002" title="SindrupSH , GramLF , BrosenK , EshojO , MogensenEF . The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain1990;42:135‐44. ">Sindrup 1990</a>), suggesting an immediate action on sodium channels, and a mechanism of action different from that of its antidepressant effect. </p> <p>Short‐term studies (less than six weeks) may not accurately predict longer term efficacy in chronic conditions, and only one of the included studies lasted longer than five weeks. Furthermore, caution is required in interpreting adverse event data from short duration studies for real‐world clinical practice, particularly when so few participants have been studied. </p> </section> <section id="CD010769-sec-0082"> <h3 class="title" id="CD010769-sec-0082">Quality of the evidence</h3> <p>Reporting quality in the studies was generally poor by current standards. Although all the studies were randomised and double‐blind, none provided data that met predefined criteria for first or second tier analysis. All the studies were small (with a maximum of 40 participants in any treatment arm), and four of the five were of short duration (five weeks or less), used cross‐over design without separate reporting of first period data, and reported only on participants who completed more than one phase of treatment. </p> <p>Differential rates of adverse events between placebo and treatment arms can suggest unblinding, but in these studies adverse events were assessed inconsistently, making comparisons difficult. <a href="./references#CD010769-bbs2-0005" title="TurkingtonRW . Depression masquerading as diabetic neuropathy. Journal American Medical Association1980;243(11):1147‐50. ">Turkington 1980</a> used an active placebo to help maintain blinding but reported no adverse events or withdrawals. None of the studies reported whether they asked participants to guess their allocation at the end of the trial to check for unblinding. The methods used to collect adverse events could usefully include symptom checklists for self‐completion at baseline and at assessment points; these can even be graded for severity. </p> </section> <section id="CD010769-sec-0083"> <h3 class="title" id="CD010769-sec-0083">Potential biases in the review process</h3> <p>The review was restricted to randomised double‐blind studies, thus limiting the potential for bias. Other possible sources of bias that could have affected the review included the following: </p> <p> <ul id="CD010769-list-0008"> <li> <p>Duration ‐ NNT estimates of efficacy in chronic pain studies tend to increase (get worse) with increasing duration (<a href="./references#CD010769-bbs2-0041" title="MooreRA , MooreOA , DerryS , PelosoPM , GammaitoniAR , WangH . Responder analysis for pain relief and numbers needed to treat in a meta‐analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice. Annals of the Rheumatic Diseases2010;69(2):374‐9. [DOI: doi:10.1136/ard.2009.107805] ">Moore 2010b</a>). All studies except one were five weeks or shorter, which may overestimate efficacy. </p> </li> <li> <p>Only one study reported an outcome equivalent to IMMPACT‐defined moderate or substantial improvement. It is likely that lesser benefits, such as 'any benefit' or 'any improvement', are potentially related to inferior outcomes, although this remains to be clarified. </p> </li> <li> <p>The degree of exaggeration of treatment effects in cross‐over trials compared with parallel group designs, as has been seen in some circumstances (<a href="./references#CD010769-bbs2-0029" title="KhanKS , DayaS , JadadA . The importance of quality of primary studies in producing unbiased systematic reviews. Archives of Internal Medicine1996;156(6):661‐6. ">Khan 1996</a>), is unclear but unlikely to be the source of major bias (<a href="./references#CD010769-bbs2-0020" title="ElbourneDR , AltmanDG , HigginsJP , CurtinF , WorthingtonHV , VailA . Meta‐analyses involving cross‐over trials: methodological issues. International Journal of Epidemiology2002;31(1):140‐9. [DOI: 10.1093/ije/31.1.140] ">Elbourne 2002</a>). Withdrawals meant that any results were more likely to be per protocol for completers than for a true ITT analysis. Most of the data in this review were from cross‐over studies. </p> </li> <li> <p>The absence of publication bias (unpublished trials showing no benefit of imipramine over placebo) can never be proven. We carried out a broad search for studies and feel it is unlikely that significant amounts of data remain unknown to us. </p> </li> <li> <p>All four cross‐over studies reported results only for those who completed at least two treatment periods, which is likely to overestimate efficacy. Where possible, we have added missing participants back into the denominator to provide an ITT analysis and thus a more conservative estimate. </p> </li> </ul> </p> </section> <section id="CD010769-sec-0084"> <h3 class="title" id="CD010769-sec-0084">Agreements and disagreements with other studies or reviews</h3> <p>This new review does not change the results of the previous Cochrane review (<a href="./references#CD010769-bbs2-0070" title="SaartoT , WiffenPJ . Antidepressants for neuropathic pain. Cochrane Database of Systematic Reviews2007, Issue 4. [DOI: 10.1002/14651858.CD005454.pub2] ">Saarto 2007</a>). </p> <p>Guidelines to treat neuropathic pain in Europe, UK, and USA do not specifically recommend use of imipramine (<a href="./references#CD010769-bbs2-0012" title="AttalN , CruccuG , BaronR , HaanpääM , HanssonP , JensenTS , et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. European Journal of Neurology2010;17(9):1113‐e88. [DOI: 10.1111/j.1468‐1331.2010.02999.x] ">Attal 2010</a>; <a href="./references#CD010769-bbs2-0055" title="NICE clinical guideline 173. Neuropathic pain – pharmacological management. www.nice.org.uk/guidance/CG173 (accessed 4 December 2013)2013:1‐138. ">NICE 2013</a>; <a href="./references#CD010769-bbs2-0019" title="DworkinRH , O'ConnorAB , AudetteJ , BaronR , GourlayGK , HaanpääML , et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clinic Proceedings2010;85(3 Suppl):S3‐14. [DOI: 10.4065/mcp.2009.0649] ">Dworkin 2010</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010769-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010769.pub2/media/CDSR/CD010769/urn:x-wiley:14651858:media:CD010769:CD010769-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010769.pub2/media/CDSR/CD010769/image_t/tCD010769-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Flow diagram." data-id="CD010769-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010769.pub2/media/CDSR/CD010769/image_n/nCD010769-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010769.pub2/full#CD010769-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010769.pub2/media/CDSR/CD010769/image_n/nCD010769-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010769-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010769.pub2/media/CDSR/CD010769/urn:x-wiley:14651858:media:CD010769:CD010769-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010769.pub2/media/CDSR/CD010769/image_t/tCD010769-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010769-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010769.pub2/media/CDSR/CD010769/image_n/nCD010769-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010769.pub2/full#CD010769-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010769.pub2/media/CDSR/CD010769/image_n/nCD010769-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010769-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010769.pub2/media/CDSR/CD010769/urn:x-wiley:14651858:media:CD010769:CD010769-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010769.pub2/media/CDSR/CD010769/image_t/tCD010769-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010769-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010769.pub2/media/CDSR/CD010769/image_n/nCD010769-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010769.pub2/full#CD010769-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010769.pub2/media/CDSR/CD010769/image_n/nCD010769-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010769-tbl-0001"> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Imipramine compared with placebo for painful diabetic neuropathy and polyneuropathy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population: neuropathic pain (5 studies in painful diabetic neuropathy and polyneuropathy)</b> </p> <p><b>Settings: community</b> </p> <p><b>Intervention: imipramine 25 to 350 mg daily</b> </p> <p><b>Comparison: placebo</b> </p> </td> </tr> <tr class="table-header separated"> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Probable outcome with comparator (placebo)</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Probable outcome with intervention</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>RR (95% CI)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>At least 50% reduction in pain or equivalent</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"Moderate" benefit</p> <p>At least 30% reduction in pain</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion below 30/100 mm on VAS</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Patient Global Impression of Change much or very much improved</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>2/40</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>9/40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not calculated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40 participants</p> <p>1 study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Small numbers of participants in 1 study, cross‐over design</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse event withdrawals</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>3/109</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>3 during dose‐finding open label treatment (denominator unknown)</p> <p>4/109 during double blind treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not calculated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>109 participants</p> <p>4 studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Small numbers of studies and participants</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>1 "unrelated" hospitalisation for a "pronounced" urinary tract infection. Treatment group not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not calculated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>168 participants</p> <p>5 studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Small numbers of studies and participants</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Death</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>None reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>168 participants</p> <p>5 studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Small numbers of studies and participants</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>CI: confidence interval; RR: risk ratio.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-title"></span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010769.pub2/full#CD010769-tbl-0001">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010769.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010769-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010769-note-0004">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD010769-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD010769-note-0001">Hrvatski</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD010769-note-0007">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010769\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010769\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010769\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010769\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010769\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010769\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010769\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010769\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010769\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010769\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010769\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010769\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010769\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010769\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010769\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010769\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010769\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010769\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=loVWuZlx&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010769.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010769.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010769.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010769.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010769.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740719862905"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010769.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740719862908"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010769.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918df32219d0937f',t:'MTc0MDcxOTg2My4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 